Whole-brain R1 predicts manganese exposure and biological effects in welders

David A Edmondson1,2,3, Chien-Lin Yeh1,2, Sébastien Hélie4

  • 1School of Health Sciences, Purdue University, 550 Stadium Dr., Hampton Hall of Civil Engineering, West Lafayette, IN, 47907, USA.

Archives of Toxicology
|September 3, 2020
PubMed

Insights

Manganese (Mn) brain accumulation, detected by MRI R1 maps, accurately predicts high air Mn concentration and years welding. Lower exposures show no clear brain signature.

Area of Science:

  • Neuroscience
  • Radiology
  • Occupational Health

Background:

  • Manganese (Mn) is a neurotoxicant and a paramagnetic substance used as an MRI T1 contrast agent.
  • Mn accumulation in the brain is linked to neurological disorders, including parkinsonian symptoms.

Purpose of the Study:

  • To investigate the relationship between manganese exposure, brain manganese accumulation, and neurological indicators using machine learning.
  • To determine if MRI R1 maps can identify individuals with higher manganese exposure and associated neurological changes.

Main Methods:

  • Support vector machines (SVM) were trained using whole-brain R1 maps from 57 welders and 32 controls.
  • Classification was based on air Mn concentration ([Mn]Air), brain Mn accumulation (ExMnBrain), motor dysfunction (UPDRS), and thalamic GABA concentration (GABAThal).
  • SVM was also used to predict age to validate results against Mn exposure.

Main Results:

  • R1 maps accurately predicted air Mn concentration above 0.20 mg/m³ (88.8% accuracy, 88.9% recall).
  • R1 predicted lower thalamic GABA concentrations (≤ 2.6 mM) with 82% accuracy and 78.9% recall.
  • R1 predicted age below 48 years (75-82% accuracy) but not above, suggesting Mn-specific signatures are linked to cumulative exposure.

Conclusions:

  • Higher manganese air exposures and longer welding durations result in identifiable brain signatures detectable by SVM using R1 maps.
  • Lower levels of manganese exposure (< 0.20 mg/m³ and < 18 years welding) do not produce discernible brain signatures.
  • MRI R1 mapping combined with SVM is a promising tool for assessing occupational manganese exposure and its neurological impact.

Related Concept Videos